Sheng Xie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sheng Xie has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
Liqun Li
The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning 530001, Guangxi, China
5 shared publications- Jing Yan
Graduate School of Guangxi University of Chinese Medicine, Nanning, Guangxi, China
4 shared publications Jinjing Tan
The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning 530001, Guangxi, China
4 shared publications- Jinjing Tan
The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, Guangxi, China
4 shared publications Lijian Liu
The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning 530001, Guangxi, China
4 shared publications- Lijian Mm Liu
The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, Guangxi, China
4 shared publications
Latest Publications
- Open Access
- 6 April 2026
- Published by Elsevier in Immunobiology
- Vol. 231 (3) , 153180
Silencing core circadian regulators CLOCK and BMAL1 inhibits autophagy in interstitial cells of Cajal in a gastroesophageal reflux disease model
- 6 April 2026
- Published by Elsevier in Immunobiology
- Vol. 231 (3) , 153180
Open AccessSilencing core circadian regulators CLOCK and BMAL1 inhibits autophagy in interstitial cells of Cajal in a gastroesophageal reflux disease model
- Open Access
- 13 February 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (7) , e47458
Causal relationships between antibody-induced immune responses and sepsis: Evidence from genetic studies
The causal relationships between antibody-induced immune responses and the occurrence and mortality of sepsis remain controversial. The 2-sample Mendelian randomization (MR) approach was utilized to reveal the causal associations, along with the potential mediation effects of inflammatory cytokines. The causal associations were analyzed by a 2-sample bidirectional MR analysis, primarily using the inverse variance weighted method. MR-Egger regression, weighted mode, weighted median, and simple mode were conducted as supplementary analyses. Additionally, we performed a 2-step MR to investigate the potential mediation effects of 91 inflammatory cytokines. Cochran Q test was conducted to assess statistical heterogeneity. Potential horizontal pleiotropy was identified with MR-Egger regression intercept test and MR-pleiotropy residual sum and outlier global test. Leave-one-out sensitivity analysis was employed to evaluate the influence of an individual single nucleotide polymorphism on the estimates. The outcomes revealed positive associations between genetically predicted Helicobacter pylori urea antibody levels (odds ratios [ORs] = 1.070, 95% confidence interval [CI]: 1.009–1.134, P = .024), anti-herpes simplex virus type 1 immunoglobulin G seropositivity [OR = 1.071, 95% CI: 1.012–1.134, P = .018], and the risk of sepsis; cytomegalovirus phosphoprotein 52 antibody levels showed significant negative correlation with 28-day mortality in sepsis [OR = 0.830, 95% CI: 0.690–0.999, P = .048]. Surprisingly, the mediation analysis suggested that the 91 inflammatory cytokines did not mediate these associations. H pylori urea antibody and anti-herpes simplex virus type 1 immunoglobulin G seropositivity are pathogenic factors for sepsis, while cytomegalovirus phosphoprotein 52 antibody levels may protect against 28-day mortality in sepsis. Inflammatory cytokines may not mediate these relationships. These findings could contribute to the precise management of sepsis.
- 13 February 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (7) , e47458
Open AccessCausal relationships between antibody-induced immune responses and sepsis: Evidence from genetic studies
The causal relationships between antibody-induced immune responses and the occurrence and mortality of sepsis remain controversial. The 2-sample Mendelian randomization (MR) approach was utilized to reveal the causal associations, along with the potential mediation effects of inflammatory cytokines. The causal associations were analyzed by a 2-sample bidirectional MR analysis, primarily using the inverse variance weighted method. MR-Egger regression, weighted mode, weighted median, and simple mode were conducted as supplementary analyses. Additionally, we performed a 2-step MR to investigate the potential mediation effects of 91 inflammatory cytokines. Cochran Q test was conducted to assess statistical heterogeneity. Potential horizontal pleiotropy was identified with MR-Egger regression intercept test and MR-pleiotropy residual sum and outlier global test. Leave-one-out sensitivity analysis was employed to evaluate the influence of an individual single nucleotide polymorphism on the estimates. The outcomes revealed positive associations between genetically predicted Helicobacter pylori urea antibody levels (odds ratios [ORs] = 1.070, 95% confidence interval [CI]: 1.009–1.134, P = .024), anti-herpes simplex virus type 1 immunoglobulin G seropositivity [OR = 1.071, 95% CI: 1.012–1.134, P = .018], and the risk of sepsis; cytomegalovirus phosphoprotein 52 antibody levels showed significant negative correlation with 28-day mortality in sepsis [OR = 0.830, 95% CI: 0.690–0.999, P = .048]. Surprisingly, the mediation analysis suggested that the 91 inflammatory cytokines did not mediate these associations. H pylori urea antibody and anti-herpes simplex virus type 1 immunoglobulin G seropositivity are pathogenic factors for sepsis, while cytomegalovirus phosphoprotein 52 antibody levels may protect against 28-day mortality in sepsis. Inflammatory cytokines may not mediate these relationships. These findings could contribute to the precise management of sepsis.
- 30 December 2025
- Published by Elsevier in Tissue and Cell
- Vol. 99, 103299
Modified Xuan-Bi-Qing-Ying decoction alleviates septic liver injury by regulating autophagy and apoptosis via HIF-1α signaling pathway
- 30 December 2025
- Published by Elsevier in Tissue and Cell
- Vol. 99, 103299
Modified Xuan-Bi-Qing-Ying decoction alleviates septic liver injury by regulating autophagy and apoptosis via HIF-1α signaling pathway
- Open Access
- 5 September 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (36) , e44301
Genetic evidence for causal associations between common cell-derived signaling molecules and sleep disorders and the mediating role of metabolites
Although the potential causal associations between cell-derived signaling molecules and sleep disorder (SD) have been reported, contradictions remain. This study assessed the causal effects and the mediating role of 1400 metabolites among 91 cell-derived signaling molecules and SD from a genetic perspective by performing Mendelian randomization (MR) analyses. Genetic instruments derived from publicly available genome-wide association studies were employed in this study, including 49,880 SD cases and 358,194 controls. Summary statistics of 1400 circulating metabolites were obtained from a cohort of 8299 individuals. The 91 cell-derived signaling molecules were derived from genome-wide association studies data from 11 cohorts comprising 14,824 samples. Multiple statistical analyses were introduced in this study, with inverse variance weighted as the core analysis method, supplemented by 4 additional methods. Besides, various sensitivity analyses were employed to identify horizontal pleiotropy and heterogeneity, thereby evaluating the robustness of the results. Forward MR analysis indicated positive associations between SD and the levels of eotaxin (OR = 1.041, 95% CI: 1.001–1.084, P = .046), CUB domain-containing protein 1 (OR = 1.042, 95% CI: 1.008–1.077, P = .016), interleukin-20 receptor subunit alpha (IL-20RA) (OR = 1.086, 95% CI: 1.031–1.143, P = .002), while the levels of CD40L receptor (OR = 0.968, 95% CI: 0.942–0.994, P = .018), glial cell line-derived neurotrophic factor (OR = 0.947, 95% CI: 0.910–0.986, P = .009) act as the opposite. Reverse MR analysis pointed out that the genetic susceptibility to SD raised interleukin-5 levels. According to the mediation analysis, N-lactoyl-tyrosine levels mediated the increased risks of SD associated with elevated IL-20RA levels, with a mediation effect of 0.009 (95% CI: 0.001–0.018, P = .034), accounting for 11.5% of the total. The study proved the causal associations between 91 cell-derived signaling molecules and SD, confirming that eotaxin, CUB domain-containing protein 1, and IL-20RA may increase the risk of SD, while CD40L receptor and glial cell line-derived neurotrophic factor may act as the opposite. Besides, the study provided abundant evidence for the potential mediating effect of N-lactoyl-tyrosine in the pathway linking IL-20RA and SD risk. To summarize, the findings of this study may benefit the understanding of the pathogenic mechanisms through which cell-derived signaling molecules influence SD.
- 5 September 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (36) , e44301
Open AccessGenetic evidence for causal associations between common cell-derived signaling molecules and sleep disorders and the mediating role of metabolites
Although the potential causal associations between cell-derived signaling molecules and sleep disorder (SD) have been reported, contradictions remain. This study assessed the causal effects and the mediating role of 1400 metabolites among 91 cell-derived signaling molecules and SD from a genetic perspective by performing Mendelian randomization (MR) analyses. Genetic instruments derived from publicly available genome-wide association studies were employed in this study, including 49,880 SD cases and 358,194 controls. Summary statistics of 1400 circulating metabolites were obtained from a cohort of 8299 individuals. The 91 cell-derived signaling molecules were derived from genome-wide association studies data from 11 cohorts comprising 14,824 samples. Multiple statistical analyses were introduced in this study, with inverse variance weighted as the core analysis method, supplemented by 4 additional methods. Besides, various sensitivity analyses were employed to identify horizontal pleiotropy and heterogeneity, thereby evaluating the robustness of the results. Forward MR analysis indicated positive associations between SD and the levels of eotaxin (OR = 1.041, 95% CI: 1.001–1.084, P = .046), CUB domain-containing protein 1 (OR = 1.042, 95% CI: 1.008–1.077, P = .016), interleukin-20 receptor subunit alpha (IL-20RA) (OR = 1.086, 95% CI: 1.031–1.143, P = .002), while the levels of CD40L receptor (OR = 0.968, 95% CI: 0.942–0.994, P = .018), glial cell line-derived neurotrophic factor (OR = 0.947, 95% CI: 0.910–0.986, P = .009) act as the opposite. Reverse MR analysis pointed out that the genetic susceptibility to SD raised interleukin-5 levels. According to the mediation analysis, N-lactoyl-tyrosine levels mediated the increased risks of SD associated with elevated IL-20RA levels, with a mediation effect of 0.009 (95% CI: 0.001–0.018, P = .034), accounting for 11.5% of the total. The study proved the causal associations between 91 cell-derived signaling molecules and SD, confirming that eotaxin, CUB domain-containing protein 1, and IL-20RA may increase the risk of SD, while CD40L receptor and glial cell line-derived neurotrophic factor may act as the opposite. Besides, the study provided abundant evidence for the potential mediating effect of N-lactoyl-tyrosine in the pathway linking IL-20RA and SD risk. To summarize, the findings of this study may benefit the understanding of the pathogenic mechanisms through which cell-derived signaling molecules influence SD.
- Open Access
- 8 August 2025
- Published by Springer Nature in Hereditas
- Vol. 162 (1) , 153
Integrating bioinformatics analysis, machine learning, and experimental validation to identify pyroptosis-related genes in the diagnosis of sepsis combined with acute liver failure
Background: Sepsis is frequently combined with acute liver failure (ALF), a critical determinant in the mortality of septic patients. Pyroptosis is a significant form of programmed cell death that plays an important role in the inflammatory response. Research has been conducted to elucidate the relationship between pyroptosis, sepsis, and ALF, but the mechanism of action remains unclear. Methods: Datasets relating to sepsis and ALF were obtained from the Gene Expression Omnibus (GEO). The intersection of differentially expressed genes (DEGs) and pyroptosis-related genes for sepsis and ALF was identified. Simultaneously, a gene diagnosis model for sepsis and ALF was developed using machine learning, and the model’s accuracy was assessed through the plotting of the ROC curves and confusion matrix. The Hub genes identified by the model with an area under the curve (AUC) value ≥ 0.7 were used for the investigation of immune cell infiltration to explain the molecular mechanism of sepsis combined with ALF. The precise mechanism of action of these model genes in sepsis combined with ALF was evaluated through animal experiments. Results: Machine learning revealed that GABARAP and ITCH may serve as diagnostic biomarkers for pyroptosis in sepsis combined with ALF. The examination of immune cell infiltration indicated that immune dysregulation is present in both sepsis and ALF and preliminarily suggested that GABARAP and ITCH may be pivotal in cellular immunity responses, particularly those mediated by T cells. Animal experiments further validated that in the process of sepsis combined with ALF, the expression level of GABARAP is elevated, while the expression level of ITCH is diminished. Conclusions: We found GABARAP and ITCH may serve as diagnostic biomarkers for pyroptosis in sepsis combined with ALF, suggesting their potential involvement in the initiation and advancement of sepsis combined with ALF through cellular immunomodulatory pathways. Clinical trial number: Not applicable.
- 8 August 2025
- Published by Springer Nature in Hereditas
- Vol. 162 (1) , 153
Open AccessIntegrating bioinformatics analysis, machine learning, and experimental validation to identify pyroptosis-related genes in the diagnosis of sepsis combined with acute liver failure
Background: Sepsis is frequently combined with acute liver failure (ALF), a critical determinant in the mortality of septic patients. Pyroptosis is a significant form of programmed cell death that plays an important role in the inflammatory response. Research has been conducted to elucidate the relationship between pyroptosis, sepsis, and ALF, but the mechanism of action remains unclear. Methods: Datasets relating to sepsis and ALF were obtained from the Gene Expression Omnibus (GEO). The intersection of differentially expressed genes (DEGs) and pyroptosis-related genes for sepsis and ALF was identified. Simultaneously, a gene diagnosis model for sepsis and ALF was developed using machine learning, and the model’s accuracy was assessed through the plotting of the ROC curves and confusion matrix. The Hub genes identified by the model with an area under the curve (AUC) value ≥ 0.7 were used for the investigation of immune cell infiltration to explain the molecular mechanism of sepsis combined with ALF. The precise mechanism of action of these model genes in sepsis combined with ALF was evaluated through animal experiments. Results: Machine learning revealed that GABARAP and ITCH may serve as diagnostic biomarkers for pyroptosis in sepsis combined with ALF. The examination of immune cell infiltration indicated that immune dysregulation is present in both sepsis and ALF and preliminarily suggested that GABARAP and ITCH may be pivotal in cellular immunity responses, particularly those mediated by T cells. Animal experiments further validated that in the process of sepsis combined with ALF, the expression level of GABARAP is elevated, while the expression level of ITCH is diminished. Conclusions: We found GABARAP and ITCH may serve as diagnostic biomarkers for pyroptosis in sepsis combined with ALF, suggesting their potential involvement in the initiation and advancement of sepsis combined with ALF through cellular immunomodulatory pathways. Clinical trial number: Not applicable.
- Open Access
- 11 July 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (28) , e43254
Association between antibody-mediated immune responses and gastroesophageal reflux disease: Evidence from genetic studies
Studies have proven an association between the specific antibody-mediated immune response and gastroesophageal reflux disease (GERD); however, the exact causal associations remain unclear. Our research aims to evaluate the causal relationships between the genetic susceptibility to 46 antibody-mediated immune responses and GERD, with the bidirectional two-sample Mendelian randomization (TSMR) and to explore the mediating effects of 91 circulating inflammatory cytokines by a two-step MR analysis. Multiple MR analysis methods, including inverse variance weighted, MR-Egger, weighted mode, weighted median, simple mode, and MR pleiotropy residual sum and outlier, were employed for the bidirectional TSMR analysis. Besides, sensitivity analyses, such as Cochran Q statistics, MR-Egger intercept, MR pleiotropy residual sum and outlier global test, and the leave-one-out method were implemented to identify potential heterogeneity and pleiotropy. In the forward MR analysis, the inverse variance weighted method demonstrated that anti-cytomegalovirus (anti-CMV) IgG seropositivity (OR = 1.031, 95% CI: 1.000–1.062, P = .048), levels of human herpes virus (HHV) 7 U14 antibody (OR = 1.097, 95% CI: 1.032–1.167, P = .003), and herpes simplex virus 1 (HSV-1) mgG-1 antibody (OR = 1.069, 95% CI: 1.020–1.119, P = .005), which have higher genetic prediction, are positively related to GERD risks. Reverse MR analysis revealed GERD increased the level of Epstein–Barr virus VCA p18 antibody (OR = 1.255, 95% CI: 1.028–1.533, P = .026), while decreased the anti-CMV IgG seropositivity (OR = 0.663, 95% CI: 0.444–0.991, P = .045) and HHV 7 U14 antibody level (OR = 0.777, 95% CI: 0.630–0.958, P = .018) as well. Besides, other antibodies, including anti-Helicobacter pylori (H pylori) IgG, H pylori CagA, and H pylori VacA demonstrated no correlations (neither positive nor negative) with GERD risks. Surprisingly, TSMR showed that 91 cytokines seemed not to mediate HSV-1 mgG-1 to enhance GERD risks. The research provided convincing evidence for establishing a causal relationship between antibody-mediated immune responses and GERD, proving that genetic-prediction-based HSV-1 mgG-1 could increase GERD risk and that inflammatory factors may not be involved in mediating this association. Besides, GERD was found to reduce Epstein–Barr virus VCA p18 antibody. Moreover, we revealed the bidirectional causal relationships between GERD and the antibodies, including anti-CMV IgG, HHV 7 U14. This research may contribute to a better understanding of the mechanism that triggers GERD, also emphasizing the clinical potential of therapeutic interventions targeting antibody-mediated immune responses.
- 11 July 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (28) , e43254
Open AccessAssociation between antibody-mediated immune responses and gastroesophageal reflux disease: Evidence from genetic studies
Studies have proven an association between the specific antibody-mediated immune response and gastroesophageal reflux disease (GERD); however, the exact causal associations remain unclear. Our research aims to evaluate the causal relationships between the genetic susceptibility to 46 antibody-mediated immune responses and GERD, with the bidirectional two-sample Mendelian randomization (TSMR) and to explore the mediating effects of 91 circulating inflammatory cytokines by a two-step MR analysis. Multiple MR analysis methods, including inverse variance weighted, MR-Egger, weighted mode, weighted median, simple mode, and MR pleiotropy residual sum and outlier, were employed for the bidirectional TSMR analysis. Besides, sensitivity analyses, such as Cochran Q statistics, MR-Egger intercept, MR pleiotropy residual sum and outlier global test, and the leave-one-out method were implemented to identify potential heterogeneity and pleiotropy. In the forward MR analysis, the inverse variance weighted method demonstrated that anti-cytomegalovirus (anti-CMV) IgG seropositivity (OR = 1.031, 95% CI: 1.000–1.062, P = .048), levels of human herpes virus (HHV) 7 U14 antibody (OR = 1.097, 95% CI: 1.032–1.167, P = .003), and herpes simplex virus 1 (HSV-1) mgG-1 antibody (OR = 1.069, 95% CI: 1.020–1.119, P = .005), which have higher genetic prediction, are positively related to GERD risks. Reverse MR analysis revealed GERD increased the level of Epstein–Barr virus VCA p18 antibody (OR = 1.255, 95% CI: 1.028–1.533, P = .026), while decreased the anti-CMV IgG seropositivity (OR = 0.663, 95% CI: 0.444–0.991, P = .045) and HHV 7 U14 antibody level (OR = 0.777, 95% CI: 0.630–0.958, P = .018) as well. Besides, other antibodies, including anti-Helicobacter pylori (H pylori) IgG, H pylori CagA, and H pylori VacA demonstrated no correlations (neither positive nor negative) with GERD risks. Surprisingly, TSMR showed that 91 cytokines seemed not to mediate HSV-1 mgG-1 to enhance GERD risks. The research provided convincing evidence for establishing a causal relationship between antibody-mediated immune responses and GERD, proving that genetic-prediction-based HSV-1 mgG-1 could increase GERD risk and that inflammatory factors may not be involved in mediating this association. Besides, GERD was found to reduce Epstein–Barr virus VCA p18 antibody. Moreover, we revealed the bidirectional causal relationships between GERD and the antibodies, including anti-CMV IgG, HHV 7 U14. This research may contribute to a better understanding of the mechanism that triggers GERD, also emphasizing the clinical potential of therapeutic interventions targeting antibody-mediated immune responses.
- Open Access
- 30 May 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (22) , e42426
Causal relationships between 91 inflammatory cytokines and gastroesophageal reflux disease, and the mediating role of related metabolites: Evidence from genetics
The associations between specific inflammatory cytokines and gastroesophageal reflux disease (GERD) have been confirmed, while their causal relationships remain unclear. We conducted a bidirectional 2-sample Mendelian randomization analysis (MRA) to reveal the causal correlations between 91 inflammatory factors and GERD, thereby conducting a 2-step MRA analysis to reveal the mediating function of 1400 metabolites therein. Data related to 91 inflammatory cytokines were derived from Genome-Wide Association Studies (GWAS) data with 14,824 samples. GWAS data about GERD were obtained from a large genome research project in Finland, including 28,859 GERD cases and 3,50,064 controls. GWAS data about 1400 circulating metabolites were derived from a cohort of 8299 individuals. The inverse variance weighted approach was introduced to obtain the primary MRA results, complemented by 4 additional methods for supportive analyses. Additionally, the study conducted sensitivity analyses with different methods to evaluate heterogeneity and horizontal pleiotropy. Our findings indicated that higher predicted C-X-C motif chemokine 1 [OR = 1.052, 95% CI: 1.004 − 1.103, P = .035], interleukin-1-alpha [OR = 1.083, 95% CI: 1.018 − 1.152, P = .012], and interleukin-4 [IL-4, OR = 1.081, 95% CI: 1.018 − 1.147, P = .011] increased the risk of GERD; whereas tumor necrosis factor ligand superfamily member 12 [OR = 0.958, 95% CI: 0.9174–0.9999, P = .0493] decreased the risk of GERD. No significant statistical differences were found for other inflammatory cytokines. Genetic susceptibility to GERD had no impact on any traits related to circulating inflammatory cytokines. Four metabolites associated with elevated IL-4 levels were identified, including (1-enyl-oleoyl)-GPE (P-18:1), 4-methyl guaiacol sulfate, X-12730, and X-17685, but their mediating effects were not statistically significant (P > .05). This study convincingly proved the causal impact of inflammatory factors on GERD. It confirms that C-X-C motif chemokine 1, interleukin-1-alpha, and IL-4 increase the risk of GERD, while tumor necrosis factor ligand superfamily member 12 reduces it. Additionally, several circulating metabolites are associated with elevated IL-4 levels. However, the evidence for their role as potential mediators in the pathway between IL-4 and GERD risk remains insufficient. The findings of this study propel further comprehension of the pathogenesis of GERD and also point out the therapeutic potential for interventions targeting inflammatory cytokine-targeted inventions.
- 30 May 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (22) , e42426
Open AccessCausal relationships between 91 inflammatory cytokines and gastroesophageal reflux disease, and the mediating role of related metabolites: Evidence from genetics
The associations between specific inflammatory cytokines and gastroesophageal reflux disease (GERD) have been confirmed, while their causal relationships remain unclear. We conducted a bidirectional 2-sample Mendelian randomization analysis (MRA) to reveal the causal correlations between 91 inflammatory factors and GERD, thereby conducting a 2-step MRA analysis to reveal the mediating function of 1400 metabolites therein. Data related to 91 inflammatory cytokines were derived from Genome-Wide Association Studies (GWAS) data with 14,824 samples. GWAS data about GERD were obtained from a large genome research project in Finland, including 28,859 GERD cases and 3,50,064 controls. GWAS data about 1400 circulating metabolites were derived from a cohort of 8299 individuals. The inverse variance weighted approach was introduced to obtain the primary MRA results, complemented by 4 additional methods for supportive analyses. Additionally, the study conducted sensitivity analyses with different methods to evaluate heterogeneity and horizontal pleiotropy. Our findings indicated that higher predicted C-X-C motif chemokine 1 [OR = 1.052, 95% CI: 1.004 − 1.103, P = .035], interleukin-1-alpha [OR = 1.083, 95% CI: 1.018 − 1.152, P = .012], and interleukin-4 [IL-4, OR = 1.081, 95% CI: 1.018 − 1.147, P = .011] increased the risk of GERD; whereas tumor necrosis factor ligand superfamily member 12 [OR = 0.958, 95% CI: 0.9174–0.9999, P = .0493] decreased the risk of GERD. No significant statistical differences were found for other inflammatory cytokines. Genetic susceptibility to GERD had no impact on any traits related to circulating inflammatory cytokines. Four metabolites associated with elevated IL-4 levels were identified, including (1-enyl-oleoyl)-GPE (P-18:1), 4-methyl guaiacol sulfate, X-12730, and X-17685, but their mediating effects were not statistically significant (P > .05). This study convincingly proved the causal impact of inflammatory factors on GERD. It confirms that C-X-C motif chemokine 1, interleukin-1-alpha, and IL-4 increase the risk of GERD, while tumor necrosis factor ligand superfamily member 12 reduces it. Additionally, several circulating metabolites are associated with elevated IL-4 levels. However, the evidence for their role as potential mediators in the pathway between IL-4 and GERD risk remains insufficient. The findings of this study propel further comprehension of the pathogenesis of GERD and also point out the therapeutic potential for interventions targeting inflammatory cytokine-targeted inventions.
- Open Access
- 6 September 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (36) , e39655
Association of MCP-4, NRTN, and PD-L1 with the risk of hepatic fibrosis: A Mendelian randomization study
Previous studies have confirmed the affiliation between specific inflammatory cytokines and Hepatic fibrosis (HF); however, contradictions remain in the causality. The study implemented a bidirectional two-sample Mendelian randomization (MR) analysis with published statistics derived from Genome-wide Association Studies (GWAS) to investigate casualties between inflammatory cytokines and HF. Additionally, MR analysis was also introduced to consider if 1400 blood metabolites act as the key mediators in this process. Single nucleotide polymorphisms (SNPs) with strong correlations to inflammatory factors were selected for multiple MR analyses in this study. The inverse variance weighted method (IVW) was chosen as the principal analysis, and the others as the supportive. Besides, sensitivity tests were involved to identify potential heterogeneity and pleiotropic level. IVW methods revealed that a relatively high level of prediction-based monocyte chemoattractant protein-4 (MCP-4) (95% CI: 1.014–3.336, P = .045), along with neurturin (NRTN) (95% CI: 1.204–4.004, P = .010), may increase the risk of HF; while programmed cell death 1 ligand 1 (PD-L1) (95% CI: 0.223–0.928, P = .030), showed a protective effect on HF. No significant statistical differences were detected on any other inflammatory cytokines, nor did the impact of HF genetic predisposition on the 91 circulating inflammatory cytokines-related characteristics.
- 6 September 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (36) , e39655
Open AccessAssociation of MCP-4, NRTN, and PD-L1 with the risk of hepatic fibrosis: A Mendelian randomization study
Previous studies have confirmed the affiliation between specific inflammatory cytokines and Hepatic fibrosis (HF); however, contradictions remain in the causality. The study implemented a bidirectional two-sample Mendelian randomization (MR) analysis with published statistics derived from Genome-wide Association Studies (GWAS) to investigate casualties between inflammatory cytokines and HF. Additionally, MR analysis was also introduced to consider if 1400 blood metabolites act as the key mediators in this process. Single nucleotide polymorphisms (SNPs) with strong correlations to inflammatory factors were selected for multiple MR analyses in this study. The inverse variance weighted method (IVW) was chosen as the principal analysis, and the others as the supportive. Besides, sensitivity tests were involved to identify potential heterogeneity and pleiotropic level. IVW methods revealed that a relatively high level of prediction-based monocyte chemoattractant protein-4 (MCP-4) (95% CI: 1.014–3.336, P = .045), along with neurturin (NRTN) (95% CI: 1.204–4.004, P = .010), may increase the risk of HF; while programmed cell death 1 ligand 1 (PD-L1) (95% CI: 0.223–0.928, P = .030), showed a protective effect on HF. No significant statistical differences were detected on any other inflammatory cytokines, nor did the impact of HF genetic predisposition on the 91 circulating inflammatory cytokines-related characteristics.
- Open Access
- 8 April 2021
- Published by Springer Nature in Research Square
The Associations between Inflammatory Bowel Disease and a Range of Other Diseases:Umbrella Review of Systematic Reviews and Meta-analyses
Background Multiple meta-analyses have reported inflammatory bowel diseases (IBD) are associated with an increased risk of diverse diseases, but the evidence quality remains unclear. Objectives We aimed to summarize and evaluate this existing evidence on the associations between IBD and a range of diseases a-crossed from meta-analyses. Methods PubMed, the Cochrane Library Database, Embase, Web of Science, CNKI Databases, Wanfang Databases and VIP Database were searched to obtain eligible literatures from inception to November 1, 2019. We appraised the methodological quality of the included meta-analyses using AMSTAR 2 tool, and evaluated the quality of evidence for each outcome using the GRADE approach. Results Nineteen articles covering associations between IBD and 28 types of health outcomes were included. The methodological quality of meta-analyses was rated moderate for 5.26%, low for 21.05%, and critically low for 73.68%. Overall, summary effect estimates were significant in 26 meta-analyses. The evidence quality was rated high for 3.57%, moderate for 21.43%, low for 28.57%, and very low for 46.43%. Evidence quality was high for association between IBD and an increased periodontitis risk (OR = 4.55; 95% CI, 3.00-6.19). Evidence quality was moderate for associations between IBD and an increased thyroid cancer risk (OR = 1.75; 95% CI, 1.48–2.07), myocardial infarction incidence (RR = 1.12; 95% CI, 1.05–1.21), preterm birth incidence (OR = 1.85; 95% CI, 1.67–2.05), stillbirth incidence (OR = 1.57; 95% CI, 1.03–2.38), gallstone disease prevalence (OR = 1.72; 95% CI, 1.40–2.12), and vitamin D deficiency prevalence (OR = 1.64; 95% CI, 1.30–2.08). Conclusions Though, associations between IBD and diverse diseases have been extensively studied, few of the reported associations have robust support. Further well-designed studies are essential to determine whether IBD increases the risk of other diseases.
- 8 April 2021
- Published by Springer Nature in Research Square
Open AccessThe Associations between Inflammatory Bowel Disease and a Range of Other Diseases:Umbrella Review of Systematic Reviews and Meta-analyses
Background Multiple meta-analyses have reported inflammatory bowel diseases (IBD) are associated with an increased risk of diverse diseases, but the evidence quality remains unclear. Objectives We aimed to summarize and evaluate this existing evidence on the associations between IBD and a range of diseases a-crossed from meta-analyses. Methods PubMed, the Cochrane Library Database, Embase, Web of Science, CNKI Databases, Wanfang Databases and VIP Database were searched to obtain eligible literatures from inception to November 1, 2019. We appraised the methodological quality of the included meta-analyses using AMSTAR 2 tool, and evaluated the quality of evidence for each outcome using the GRADE approach. Results Nineteen articles covering associations between IBD and 28 types of health outcomes were included. The methodological quality of meta-analyses was rated moderate for 5.26%, low for 21.05%, and critically low for 73.68%. Overall, summary effect estimates were significant in 26 meta-analyses. The evidence quality was rated high for 3.57%, moderate for 21.43%, low for 28.57%, and very low for 46.43%. Evidence quality was high for association between IBD and an increased periodontitis risk (OR = 4.55; 95% CI, 3.00-6.19). Evidence quality was moderate for associations between IBD and an increased thyroid cancer risk (OR = 1.75; 95% CI, 1.48–2.07), myocardial infarction incidence (RR = 1.12; 95% CI, 1.05–1.21), preterm birth incidence (OR = 1.85; 95% CI, 1.67–2.05), stillbirth incidence (OR = 1.57; 95% CI, 1.03–2.38), gallstone disease prevalence (OR = 1.72; 95% CI, 1.40–2.12), and vitamin D deficiency prevalence (OR = 1.64; 95% CI, 1.30–2.08). Conclusions Though, associations between IBD and diverse diseases have been extensively studied, few of the reported associations have robust support. Further well-designed studies are essential to determine whether IBD increases the risk of other diseases.
- Open Access
Associations between gastro-oesophageal reflux disease and a range of diseases: an umbrella review of systematic reviews and meta-analyses
Objective: Numerous meta-analyses have revealed the association between gastro-oesophageal reflux disease (GORD) and a range of diseases; however, the certainty of the evidence remains unclear. This study aimed to summarise and assess the certainty of evidence derived from meta-analyses. Methods: Embase, PubMed, Web of Science, Cochrane Databases of Systematic Reviews, CNKI and Wangfang databases from their inception to 22 February 2020 were queried for systematic reviews and meta-analyses on the association between GORD and various diseases. The methodological quality of the included studies was assessed using A Measurement Tool to Assess Systematic Reviews 2 (AMSTAR 2), and evidence certainty was evaluated using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system. Statistical analysis was conducted using Stata V.15. Results: Ten publications with associations between GORD and different types of diseases were included. There was high heterogeneity (I 2 >75%) among seven independent meta-analyses. Evidence for publication bias in two independent meta-analyses was also observed. According to the AMSTAR 2 approach, the methodological quality was high for 20% of meta-analyses, moderate for 10%, low for 40% and critically low for 30%. Based on GRADE approach, the certainty of evidence was high for the association between GORD and higher risk of chronic obstructive pulmonary disease (COPD) exacerbation (OR 5.37; 95% CI 2.71 to 10.64) and higher prevalence of oesophageal adenocarcinoma (OR 4.57; 95% CI 3.89 to 5.36), and it was moderate for the association between GORD and higher chronic rhinosinusitis prevalence (OR 2.16; 95% CI 1.37 to 3.48). Conclusion: The association between GORD and a range of diseases was extensively studied, and our findings revealed a high certainty of evidence of the association between GORD and an increased risk of COPD exacerbation as well as increased prevalence of oesophageal adenocarcinoma. Further investigations using systematic reviews and meta-analyses of high methodological quality that include prospective large cohort studies and adjusted confounders are warranted. PROSPERO registration number: CRD42019122264.
Open AccessAssociations between gastro-oesophageal reflux disease and a range of diseases: an umbrella review of systematic reviews and meta-analyses
Objective: Numerous meta-analyses have revealed the association between gastro-oesophageal reflux disease (GORD) and a range of diseases; however, the certainty of the evidence remains unclear. This study aimed to summarise and assess the certainty of evidence derived from meta-analyses. Methods: Embase, PubMed, Web of Science, Cochrane Databases of Systematic Reviews, CNKI and Wangfang databases from their inception to 22 February 2020 were queried for systematic reviews and meta-analyses on the association between GORD and various diseases. The methodological quality of the included studies was assessed using A Measurement Tool to Assess Systematic Reviews 2 (AMSTAR 2), and evidence certainty was evaluated using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system. Statistical analysis was conducted using Stata V.15. Results: Ten publications with associations between GORD and different types of diseases were included. There was high heterogeneity (I 2 >75%) among seven independent meta-analyses. Evidence for publication bias in two independent meta-analyses was also observed. According to the AMSTAR 2 approach, the methodological quality was high for 20% of meta-analyses, moderate for 10%, low for 40% and critically low for 30%. Based on GRADE approach, the certainty of evidence was high for the association between GORD and higher risk of chronic obstructive pulmonary disease (COPD) exacerbation (OR 5.37; 95% CI 2.71 to 10.64) and higher prevalence of oesophageal adenocarcinoma (OR 4.57; 95% CI 3.89 to 5.36), and it was moderate for the association between GORD and higher chronic rhinosinusitis prevalence (OR 2.16; 95% CI 1.37 to 3.48). Conclusion: The association between GORD and a range of diseases was extensively studied, and our findings revealed a high certainty of evidence of the association between GORD and an increased risk of COPD exacerbation as well as increased prevalence of oesophageal adenocarcinoma. Further investigations using systematic reviews and meta-analyses of high methodological quality that include prospective large cohort studies and adjusted confounders are warranted. PROSPERO registration number: CRD42019122264.